1. Home
  2. BSET vs SABS Comparison

BSET vs SABS Comparison

Compare BSET & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bassett Furniture Industries Incorporated

BSET

Bassett Furniture Industries Incorporated

HOLD

Current Price

$16.21

Market Cap

153.2M

ML Signal

HOLD

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$3.88

Market Cap

181.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSET
SABS
Founded
1902
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
153.2M
181.4M
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
BSET
SABS
Price
$16.21
$3.88
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$9.80
AVG Volume (30 Days)
20.1K
298.5K
Earning Date
01-28-2026
11-13-2025
Dividend Yield
4.88%
N/A
EPS Growth
N/A
N/A
EPS
0.90
N/A
Revenue
$330,953,000.00
$114,698.00
Revenue This Year
$3.11
N/A
Revenue Next Year
$3.00
N/A
P/E Ratio
$18.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.62
$1.00
52 Week High
$19.75
$6.60

Technical Indicators

Market Signals
Indicator
BSET
SABS
Relative Strength Index (RSI) 47.47 55.89
Support Level $15.97 $3.56
Resistance Level $16.64 $3.83
Average True Range (ATR) 0.44 0.21
MACD -0.18 -0.02
Stochastic Oscillator 22.86 57.73

Price Performance

Historical Comparison
BSET
SABS

About BSET Bassett Furniture Industries Incorporated

Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: